FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/10/046913 [Registered on: 31/10/2022] Trial Registered Prospectively
Last Modified On: 27/10/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   Clinical evaluation of siddha formulation Koozhpaanda chooranam (internal) and Powthira Ranangalukku kalimbu (external) in the management of Paganthara moolam (fistula in ano) 
Scientific Title of Study   An open, non – randomised, single arm, phase II, single centric clinical trial to evaluate the effectiveness of Siddha formulation Koozhpaanda chooranam (internal) and Powthira ranangalukku kalimbu (external) in the management of Paganthara moolam (Fistula in- Ano) among patients attending Ayothidoss pandithar hospital, National Institute of Siddha. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrRMOHANA 
Designation  PG SCHOLAR 
Affiliation  NATIONAL INSTITUTE OF SIDDHA 
Address  DEPARTMENT OF MARUTHUVAM NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM KANCHEEPURAM DIST TAMILNADU INDIA

Kancheepuram
TAMIL NADU
600047
India 
Phone  8508439127  
Fax  044-22381314  
Email  rmohana796@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrHVETHA MERLIN KUMARI 
Designation  ASSOCIATE PROFESSOR 
Affiliation  NATIONAL INSTITUTE OF SIDDHA 
Address  DEPARTMENT OF MARUTHUVAM NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM KANCHEEPURAM DIST TAMILNADU INDIA

Kancheepuram
TAMIL NADU
600047
India 
Phone  9894782366  
Fax  044-22381314  
Email  dr.vetha@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrRMOHANA 
Designation  PG SCHOLAR 
Affiliation  NATIONAL INSTITUTE OF SIDDHA 
Address  DEPARTMENT OF MARUTHUVAM NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM KANCHEEPURAM DIST TAMILNADU INDIA

Kancheepuram
TAMIL NADU
600047
India 
Phone  8508439127  
Fax  044-22381314  
Email  rmohana796@gmail.com  
 
Source of Monetary or Material Support  
Department of Maruthuvam Ayothidoss pandithar hospital National institute of siddha Tambaram sanatorium Chennai-47 
 
Primary Sponsor  
Name  National institute of Siddha 
Address  National institute of siddha Tambaram sanatorium Chennai-47 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrR MOHANA  Ayothidoss pandithar hospital  Department of Maruthuvam Ayothidoss pandithar hospital National Institute of Siddha Tambaram sanatorium Chennai-47
Kancheepuram
TAMIL NADU 
8508439127
044-22381314
rmohana796@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical commitee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K605||Anorectal fistula. Ayurveda Condition: nil, (2) ICD-10 Condition: K928||Other specified diseases of the digestive system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Koozhpaanda chooranam(internal) Powthira ranangalukku kalimbu(external)  1.Koozhpaanda chooranam 1 gram with hot water twice a day 2.Powthira ranangalukku kalimbu external for 48 days  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Age: 20 to 60 years
2.Pus, blood and watery discharge from perianal and anal region
3.Sex: Male, Female and Transgender
4.Fistula tract within 4 cm
5.Patient who are willing to undergo kaaraseelai therapy
6.Willing to give specimen of blood for investigation whenever required
7.Willing to attend OPD or admission in IPD
8.Willing to take photograph before and after treatment
9.Patient already presenting with MRI fistulogram or willing to get the MRI from recognized laboratory
 
 
ExclusionCriteria 
Details  1.Tuberculosis (Genito urinary tract).
2.Hepatitis B & C.
3.Hemophilia and bleeding disorders.
4.Pregnancy & Lactation.
5.Uncontrolled diabetes.
6.K/H/O Cardio vascular Diseases.
7.AIDS, Syphilis.
8.K/H/O Crohn’s disease.
9.High anal fistula and complicated fistula.
10.Rectal prolapse.
11.K/H/O Rectal carcinoma.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The measurement of the tract length before and after treatment will be assessed by PDAI and good outcome of PDAI score becoming zero.  1 year 
 
Secondary Outcome  
Outcome  TimePoints 
secondary outcome is assessed by unit cutting time  1 year 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   04/11/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="2"
Days="10" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This is an open non-Randomised clinical trial that evaluates therapeutic effectiveness of siddha formulation KOOZHPAANDA CHOORANAM (INTERNAL) and POWTHIRA RANANGALUKKU KAZHIMBU (EXTERNAL) in the management of PAGANTHARA MOOLAM (FISTULA- IN ANO) patients through MRI- Fistulogram) before treatment and Perianal Disease Activity Index (PDAI) before and  aftertreatment. Fistula in-ano is the second most prevalent anorectal disorder after hemorrhoids. According to Park’s classification it classified into 4 types (Inter-sphincteric, Trans-sphincteric, Supra-sphincteric, Extra-sphincteric). The causes for fistula in ano are cryptoglandular (90%), non-cryptoglandular (10%). The cryptoglandular infection in anal region that causes abscess and pus and mucous discharge draining from external opening through fistula track. The symptoms are recurrent anal abscess, pain and swelling around anal region, bloody or foul- smell drainage (pus) from an opening around the anus, pain with bowel movement. So, my aim is to treat the Paganthara Moolam (fistula- in ano) with the Siddha formulation KOOZHPAANDA CHOORANAM (INTERNAL) and POWTHIRA RANANGALUKKU KAZHIMBU (EXTERNAL).

 

MATERIALS AND METHODS:

A Total of 20 diagnosed patients of Paganthara moolam (fistula- in ano) within the age limit of 20 -60 years willing to participate in the study, by signing the consent form will be enrolled in the study. Tuberculosis (Genito urinary tract), Hepatitis B & C, Hemophilia and bleeding disorder, Pregnancy & Lactation, Uncontrolled Diabetes, Coronary Heart Disease, AIDS & Syphilis, Crohn’s disease, High anal fistula and complicated fistula, Rectal prolapse, Rectal carcinoma will be excluded. Assessment in improvement is done through Perianal Disease Activity Index (PDAI) before and  aftertreatment.

 
Close